Table 1 (abstract PReS24-ABS-1126). Clinical parameters and results from selected aAB in patients with JIA (n=290) and RA (n=50)
From: Proceedings of the 31st European Paediatric Rheumatology Congress: part 2
| Â | PO-JIA (67) | EO-JIA (114) | SNP-JIA (66) | RFP-JIA (43) | JIA-total (290) | SNP-RA (15) | RFP-RA (35) | RA total (50) |
|---|---|---|---|---|---|---|---|---|
Mean number of aABs positive | 1,2 | 1,2 | 1,3 | 1,3 | 1,3 | 2,9 | 7,0 | 5,8 |
CTSL (%) | 1,5 | 2,6 | 3,0 | 4,7 | 2,8 | 13,3 | 48,6 | 38,0 |
FAF1 (%) | 9,0 | 6,1 | 9,1 | 4,7 | 7,2 | 0 | 0 | 0 |
HNRNPBA1 (%) | 7,5 | 3,5 | 0 | 0 | 3,1 | 6,7 | 31,4 | 24,0 |
IL37 (%) | 0 | 0 | 0 | 0 | 0 | 6,7 | 11,0 | 10,0 |
TRIM21 (Ro52) (%) | 1,5 | 0,9 | 1,5 | 4,7 | 1,7 | 13,3 | 14,3 | 14,0 |
TROVE2 (Ro60) (%) | 1,5 | 0,9 | 0 | 7,0 | 1,7 | 13,3 | 28,6 | 24,0 |
CDR2 (%) | 1,5 | 2,6 | 6,1 | 0 | 2,8 | 13,3 | 8,6 | 10,0 |
PPL (%) | 6,0 | 3,5 | 0 | 11,6 | 4,5 | 0 | 20,0 | 14,0 |